• 2024
  Sabaté-Elabbadi A, Brolon L, Brun-Buisson C, Guillemot D, Fartoukh M, Watier L, Trends in hospitalisations for lower respiratory infections after the COVID-19 pandemic in France., J Infect 2024 Sep; (): 106287.
• 2024
  Quentin Leclerc, Audrey Duval, Didier Guillemot, Lulla Opatowski, Laura Temime, Using contact network dynamics to implement efficient interventions against pathogen spread in hospital settings: A modelling study, PLoS Medicine, 2024, 21 (7), pp.e1004433. ⟨10.1371/journal.pmed.1004433⟩.
• 2023
  Pandolfi F, Brun-Buisson C, Guillemot D, Watier L, Care pathways of sepsis survivors: sequelae, mortality and use of healthcare services in France, 2015-2018., Crit Care 2023 Nov; 27(1): 438.
• 2023
  Rahbe E, Watier L, Guillemot D, Glaser P, Opatowski L, Determinants of worldwide antibiotic resistance dynamics across drug-bacterium pairs: a multivariable spatial-temporal analysis using ATLAS., Lancet Planet Health 2023 Jul; 7(7): e547-e557.
• 2023
  Ardillon A, Ramblière L, Kermorvant-Duchemin E, Sok T, Zo AZ, Diouf JB, Long P, Lach S, Sarr FD, Borand L, Cheysson F, Collard JM, Herindrainy P, de Lauzanne A, Vray M, Delarocque-Astagneau E, Guillemot D, Huynh BT, Inappropriate antibiotic prescribing and its determinants among outpatient children in 3 low- and middle-income countries: A multicentric community-based cohort study., PLoS Med 2023 Jun; 20(6): e1004211.
• 2023
  Rambliere L, de Lauzanne A, Diouf JB, Zo AZ, Landau M, Herindrainy P, Hivernaud D, Sarr FD, Sok T, Vray M, Collard JM, Borand L, Delarocque-Astagneau E, Guillemot D, Kermorvant-Duchemin E, Huynh BT, Stillbirths and neonatal mortality in LMICs: A community-based mother-infant cohort study., J Glob Health 2023 Apr; 13(): 04031.
• 2022
  Pandolfi F, Brun-Buisson C, Guillemot D, Watier L, , One-year hospital readmission for recurrent sepsis: associated risk factors and impact on 1-year mortality-a French nationwide study., Crit Care 2022 Nov; 26(1): 371.
• 2022
  de Lauzanne A, Sreng N, Foucaud E, Sok T, Chon T, Yem C, Hak V, Heng S, Soda M, Gouali M, Nadimpalli M, Inghammar M, Rabenandrasana MAN, Collard JM, Vray M, Hello SL, Kerleguer A, Piola P, Delarocque-Astagneau E, Guillemot D, Huynh BT, Borand L, Prevalence and factors associated with faecal carriage of extended-spectrum β-lactamase-producing Enterobacterales among peripartum women in the community in Cambodia., J Antimicrob Chemother 2022 Sep; 77(10): 2658-2666.
• 2022
  Abbara S, Guillemot D, El Oualydy S, Kos M, Poret C, Breant S, Brun-Buisson C, Watier L, Antimicrobial Resistance and Mortality in Hospitalized Patients with Bacteremia in the Greater Paris Area from 2016 to 2019., Clin Epidemiol 2022 ; 14(): 1547-1560.
• 2021
  Bosetti P, Huynh BT, Abdou AY, Sanchez M, Eisenhauer C, Courtejoie N, Accardo J, Salje H, Guillemot D, Moslonka-Lefebvre M, Boëlle PY, Béraud G, Cauchemez S, Opatowski L, , Lockdown impact on age-specific contact patterns and behaviours, France, April 2020., Euro Surveill 2021 12; 26(48): .
• 2021
  Huynh BT, Kermorvant-Duchemin E, Chheang R, Randrianirina F, Seck A, Hariniaina Ratsima E, Andrianirina ZZ, Diouf JB, Abdou AY, Goyet S, Ngo V, Lach S, Pring L, Sok T, Padget M, Sarr FD, Borand L, Garin B, Collard JM, Herindrainy P, de Lauzanne A, Vray M, Delarocque-Astagneau E, Guillemot D, , , Severe bacterial neonatal infections in Madagascar, Senegal, and Cambodia: A multicentric community-based cohort study., PLoS Med 2021 Sep; 18(9): e1003681.
• 2021
  Opatowski M, Brun-Buisson C, Touat M, Salomon J, Guillemot D, Tuppin P, Watier L, Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS), BMC Infect Dis 2021 Jun; 21(1): 571.
• 2021
  Cheysson F, Brun-Buisson C, Opatowski L, Le Fouler L, Caserio-Schönemann C, Pontais I, Guillemot D, Watier L, Outpatient antibiotic use attributable to viral acute lower respiratory tract infections during the cold season in France, 2010-2017, Int J Antimicrob Agents 2021 Jun; 57(6): 106339.
• 2021
  Touat M, Brun-Buisson C, Opatowski M, Salomon J, Guillemot D, Tuppin P, de Lagasnerie G, Watier L, Costs and Outcomes of 1-year post-discharge care trajectories of patients admitted with infection due to antibiotic-resistant bacteria, J Infect 2021 03; 82(3): 339-345.
• 2020
  Smith DRM, Duval A, Pouwels KB, Guillemot D, Fernandes J, Huynh BT, Temime L, Opatowski L, , , Optimizing COVID-19 surveillance in long-term care facilities: a modelling study., BMC Med 2020 12; 18(1): 386.
• 2019
  Alari A, Cheysson F, Le Fouler L, Lanotte P, , Varon E, Opatowski L, Guillemot D, Watier L, Association of Pneumococcal Conjugate Vaccine Coverage With Pneumococcal Meningitis: An Analysis of French Administrative Areas, 2001-2016, Am. J. Epidemiol. 2019 Aug;188(8):1466-1474.
• 2019
  Touat M, Opatowski M, Brun-Buisson C, Cosker K, Guillemot D, Salomon J, Tuppin P, de Lagasnerie G, Watier L, A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study, Appl Health Econ Health Policy 2019 Jun;17(3):381-389.
• 2019
  Bonneault M, Andrianoelina VH, Herindrainy P, Rabenandrasana MAN, Garin B, Breurec S, Delarocque-Astagneau E, Guillemot D, Andrianirina ZZ, Collard JM, Huynh BT, Opatowski L, Transmission Routes of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in a Neonatology Ward in Madagascar., Am J Trop Med Hyg 2019 Jun; 100(6): 1355-1362.
• 2019
  Duval A, Obadia T, Boëlle PY, Fleury E, Herrmann JL, Guillemot D, Temime L, Opatowski L, , Close proximity interactions support transmission of ESBL-K. pneumoniae but not ESBL-E. coli in healthcare settings, PLoS Comput. Biol. 2019 05;15(5):e1006496.
• 2019
  Pinotti F, Fleury É, Guillemot D, Böelle PY, Poletto C, Host contact dynamics shapes richness and dominance of pathogen strains, PLoS Comput. Biol. 2019 May;15(5):e1006530.
• 2019
  Nadimpalli M, Vuthy Y, de Lauzanne A, Fabre L, Criscuolo A, Gouali M, Huynh BT, Naas T, Phe T, Borand L, Jacobs J, Kerléguer A, Piola P, Guillemot D, Le Hello S, Delarocque-Astagneau E, Meat and Fish as Sources of Extended-Spectrum β-Lactamase-Producing Escherichia coli, Cambodia., Emerg Infect Dis 2019 Jan; 25(1): 126-31.
• 2019
  Domenech de Cellès M, Arduin H, Lévy-Bruhl D, Georges S, Souty C, Guillemot D, Watier L, Opatowski L, Unraveling the seasonal epidemiology of pneumococcus, Proc. Natl. Acad. Sci. U.S.A. 2019 01;116(5):1802-1807.
• 2019
  Opatowski M, Tuppin P, Cosker K, Touat M, De Lagasnerie G, Guillemot D, Salomon J, Brun-Buisson C, Watier L, Hospitalisations with infections related to antimicrobial-resistant bacteria from the French nationwide hospital discharge database, 2016, Epidemiol. Infect. 2019 Jan;147:e144.
• 2018
  Gao X, Huynh BT, Guillemot D, Glaser P, Opatowski L, Inference of Significant Microbial Interactions From Longitudinal Metagenomics Data, Front Microbiol 2018;9:2319.
• 2018
  Cheysson F, Vibet MA, Guillemot D, Watier L, Estimation of exposure-attributable fractions from time series: A simulation study, Stat Med 2018 Oct;37(24):3437-3454.
• 2018
  Huynh BT, Kermorvant-Duchemin E, Herindrainy P, Padget M, Rakotoarimanana FMJ, Feno H, Hariniaina-Ratsima E, Raheliarivao T, Ndir A, Goyet S, Piola P, Randrianirina F, Garin B, Collard JM, Guillemot D, Delarocque-Astagneau E, Bacterial Infections in Neonates, Madagascar, 2012-2014, Emerging Infect. Dis. 2018 04;24(4):710-717.
• 2018
  Huynh BT, Kermorvant-Duchemin E, Herindrainy P, Padget M, Rakotoarimanana FMJ, Feno H, Hariniaina-Ratsima E, Raheliarivao T, Ndir A, Goyet S, Piola P, Randrianirina F, Garin B, Collard JM, Guillemot D, Delarocque-Astagneau E, Bacterial Infections in Neonates, Madagascar, 2012-2014, Emerging Infect. Dis. 2018 04;24(4):710-717.
• 2018
  Huynh BT, Kermorvant-Duchemin E, Herindrainy P, Padget M, Rakotoarimanana FMJ, Feno H, Hariniaina-Ratsima E, Raheliarivao T, Ndir A, Goyet S, Piola P, Randrianirina F, Garin B, Collard JM, Guillemot D, Delarocque-Astagneau E, Bacterial Infections in Neonates, Madagascar, 2012-2014, Emerging Infect. Dis. 2018 04;24(4):710-717.
• 2018
  Nadimpalli M, Delarocque-Astagneau E, Love DC, Price LB, Huynh BT, Collard JM, Lay KS, Borand L, Ndir A, Walsh TR, Guillemot D, Combating Global Antibiotic Resistance: Emerging One Health Concerns in Lower- and Middle-Income Countries., Clin Infect Dis 2018 Mar; 66(6): 963-969.
• 2018
  Herindrainy P, Rabenandrasana MAN, Andrianirina ZZ, Rakotoarimanana FMJ, Padget M, de Lauzanne A, Ndir A, Kermorvant-Duchemin E, Garin B, Piola P, Collard JM, Guillemot D, Huynh BT, Delarocque-Astagneau E, Acquisition of extended spectrum beta-lactamase-producing enterobacteriaceae in neonates: A community based cohort in Madagascar., PLoS One 2018 ; 13(3): e0193325.
• 2018
  Duval A, Obadia T, Martinet L, Boëlle PY, Fleury E, Guillemot D, Opatowski L, Temime L, , Measuring dynamic social contacts in a rehabilitation hospital: effect of wards, patient and staff characteristics, Sci Rep 2018 01;8(1):1686.
• 2017
  Domenech de Cellès M, Arduin H, Varon E, Souty C, Boëlle PY, Lévy-Bruhl D, van der Werf S, Soulary JC, Guillemot D, Watier L, Opatowski L, Characterizing and Comparing the Seasonality of Influenza-Like Illnesses and Invasive Pneumococcal Diseases Using Seasonal Waveforms, Am. J. Epidemiol. 2018 05;187(5):1029-1039.
• 2016
  Alari A, Chaussade H, Domenech De Cellès M, Le Fouler L, Varon E, Opatowski L, Guillemot D, Watier L, Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis, BMC Med 2016 Dec;14(1):211.
• 2016
  Le Bourgeois M, Ferroni A, Leruez-Ville M, Varon E, Thumerelle C, Brémont F, Fayon MJ, Delacourt C, Ligier C, Watier L, Guillemot D, , Nonsteroidal Anti-Inflammatory Drug without Antibiotics for Acute Viral Infection Increases the Empyema Risk in Children: A Matched Case-Control Study, J. Pediatr. 2016 08;175:47-53.e3.
• 2016
  Padget M, Guillemot D, Delarocque-Astagneau E, Measuring antibiotic consumption in low-income countries: a systematic review and integrative approach, Int. J. Antimicrob. Agents 2016 Jul;48(1):27-32.
• 2016
  Grimaldi-Bensouda L, Abenhaim L, Massol J, Guillemot D, Avouac B, Duru G, Lert F, Magnier AM, Rossignol M, Rouillon F, Begaud B, , Homeopathic medical practice for anxiety and depression in primary care: the EPI3 cohort study, BMC Complement Altern Med 2016 May;16:125.
• 2016
  Glaser P, Martins-Simões P, Villain A, Barbier M, Tristan A, Bouchier C, Ma L, Bes M, Laurent F, Guillemot D, Wirth T, Vandenesch F, Demography and Intercontinental Spread of the USA300 Community-Acquired Methicillin-Resistant Staphylococcus aureus Lineage, MBio 2016 Feb;7(1):e02183-15.
• 2016
  Huynh BT, Padget M, Garin B, Delarocque-Astagneau E, Guillemot D, , Bacterial neonatal sepsis and antibiotic resistance in low-income countries, Lancet 2016 Feb;387(10018):533-534.
• 2016
  Leroy O, Bailly S, Gangneux JP, Mira JP, Devos P, Dupont H, Montravers P, Perrigault PF, Constantin JM, Guillemot D, Azoulay E, Lortholary O, Bensoussan C, Timsit JF, , Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study, Ann Intensive Care 2016 Dec;6(1):2.
• 2015
  Couderc C, Thiébaut AC, Lawrence C, Bouchiat C, Herrmann JL, Salomon J, Guillemot D, , Fluoroquinolone Impact on Nasal Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Colonization Durations in Neurologic Long-Term-Care Facilities, Antimicrob. Agents Chemother. 2015 Dec;59(12):7621-8.
• 2015
  Bailly S, Leroy O, Montravers P, Constantin JM, Dupont H, Guillemot D, Lortholary O, Mira JP, Perrigault PF, Gangneux JP, Azoulay E, Timsit JF, Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data, Intensive Care Med 2015 Nov;41(11):1931-40.
• 2015
  de Cellès MD, Pons-Salort M, Varon E, Vibet MA, Ligier C, Letort V, Opatowski L, Guillemot D, Interaction of Vaccination and Reduction of Antibiotic Use Drives Unexpected Increase of Pneumococcal Meningitis, Sci Rep 2015 Jun;5:11293.
• 2015
  Grimaldi-Bensouda L, Abenhaim L, Massol J, Guillemot D, Avouac B, Duru G, Lert F, Magnier AM, Rossignol M, Rouillon F, Begaud B, , Utilization of psychotropic drugs by patients consulting for sleeping disorders in homeopathic and conventional primary care settings: the EPI3 cohort study, Homeopathy 2015 Jul;104(3):170-5.
• 2015
  de Cellès MD, Pons-Salort M, Varon E, Vibet MA, Ligier C, Letort V, Opatowski L, Guillemot D, Interaction of Vaccination and Reduction of Antibiotic Use Drives Unexpected Increase of Pneumococcal Meningitis., Sci Rep. 2015 Jun 11;5:11293. doi: 10.1038/srep11293.
• 2015
  Obadia T, Opatowski L, Temime L, Herrmann JL, Fleury É, Boëlle PY, Guillemot D, Interindividual Contacts and Carriage of Methicillin-Resistant Staphylococcus aureus: A Nested Case-Control Study, Infect Control Hosp Epidemiol 2015 Aug;36(8):922-9.
• 2015
  Chereau F, Herindrainy P, Garin B, Huynh BT, Randrianirina F, Padget M, Piola P, Guillemot D, Delarocque-Astagneau E, Colonization of extended-spectrum-β-lactamase- and NDM-1-producing Enterobacteriaceae among pregnant women in the community in a low-income country: a potential reservoir for transmission of multiresistant Enterobacteriaceae to neonates, Antimicrob. Agents Chemother. 2015;59(6):3652-5.
• 2015
  Obadia T, Silhol R, Opatowski L, Temime L, Legrand J, Thiébaut AC, Herrmann JL, Fleury É, Guillemot D, Boëlle PY, , Detailed contact data and the dissemination of Staphylococcus aureus in hospitals, PLoS Comput. Biol. 2015 Mar;11(3):e1004170.
• 2015
  Obadia T, Silhol R, Opatowski L, Temime L, Legrand J, Thiébaut AC, Herrmann JL, Fleury É, Guillemot D, Boëlle PY; I-Bird Study Group, Detailed contact data and the dissemination of Staphylococcus aureus in hospitals, PLoS Comput Biol. 2015 Mar 19;11(3):e1004170. doi: 10.1371/journal.pcbi.1004170. eCollection 2015..
• 2015
  Huynh BT, Padget M, Garin B, Herindrainy P, Kermorvant-Duchemin E, Watier L, Guillemot D, Delarocque-Astagneau E, Burden of bacterial resistance among neonatal infections in low income countries: how convincing is the epidemiological evidence?, BMC Infect. Dis. 2015 Mar;15:127.
• 2014
  Roux AL, Catherinot E, Soismier N, Heym B, Bellis G, Lemonnier L, Chiron R, Fauroux B, Le Bourgeois M, Munck A, Pin I, Sermet I, Gutierrez C, Véziris N, Jarlier V, Cambau E, Herrmann JL, Guillemot D, Gaillard JL, , Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients, J. Cyst. Fibros. 2015 Jan;14(1):63-9.
• 2014
  Pons-Salort M, Serra-Cobo J, Jay F, López-Roig M, Lavenir R, Guillemot D, Letort V, Bourhy H, Opatowski L, Insights into persistence mechanisms of a zoonotic virus in bat colonies using a multispecies metapopulation model, PLoS ONE 2014;9(4):e95610.
• 2014
  Couderc C, Jolivet S, Thiébaut AC, Ligier C, Remy L, Alvarez AS, Lawrence C, Salomon J, Herrmann JL, Guillemot D, , Fluoroquinolone use is a risk factor for methicillin-resistant Staphylococcus aureus acquisition in long-term care facilities: a nested case-case-control study, Clin. Infect. Dis. 2014 Jul;59(2):206-15.
• 2014
  Grimaldi-Bensouda L, Bégaud B, Rossignol M, Avouac B, Lert F, Rouillon F, Bénichou J, Massol J, Duru G, Magnier AM, Abenhaim L, Guillemot D, Management of upper respiratory tract infections by different medical practices, including homeopathy, and consumption of antibiotics in primary care: the EPI3 cohort study in France 2007-2008, PLoS ONE 2014;9(3):e89990.
• 2014
  Lert F, Grimaldi-Bensouda L, Rouillon F, Massol J, Guillemot D, Avouac B, Duru G, Magnier AM, Rossignol M, Abenhaim L, Begaud B, , Characteristics of patients consulting their regular primary care physician according to their prescribing preferences for homeopathy and complementary medicine, Homeopathy 2014 Jan;103(1):51-7.
• 2013
  Pons-Salort M, Thiébaut AC, Guillemot D, Favre M, Delarocque-Astagneau E, HPV genotype replacement: too early to tell, Lancet Infect Dis 2013 Dec;13(12):1012.
• 2013
  Bernard E, Pons-Salort M, Favre M, Heard I, Delarocque-Astagneau E, Guillemot D, Thiébaut AC, Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies, BMC Infect. Dis. 2013;13:373.
• 2013
  Opatowski L, Varon E, Dupont C, Temime L, van der Werf S, Gutmann L, Boëlle PY, Watier L, Guillemot D, Assessing pneumococcal meningitis association with viral respiratory infections and antibiotics: insights from statistical and mathematical models, Proc. Biol. Sci. 2013 Aug;280(1764):20130519.
• 2013
  Domenech de Cellès M, Zahar JR, Abadie V, Guillemot D, Limits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric ward, BMC Infect. Dis. 2013 Apr;13:187.
• 2012
  Pons-Salort M, Letort V, Favre M, Heard I, Dervaux B, Opatowski L, Guillemot D, Exploring individual HPV coinfections is essential to predict HPV-vaccination impact on genotype distribution: a model-based approach, Vaccine 2013 Feb;31(8):1238-45.
• 2012
  Grimaldi-Bensouda L, Engel P, Massol J, Guillemot D, Avouac B, Duru G, Lert F, Magnier AM, Rossignol M, Rouillon F, Abenhaim L, Begaud B, , Who seeks primary care for sleep, anxiety and depressive disorders from physicians prescribing homeopathic and other complementary medicine? Results from the EPI3 population survey, BMJ Open 2012;2(6).
• 2012
  Domenech de Cellès M, Salomon J, Marinier A, Lawrence C, Gaillard JL, Herrmann JL, Guillemot D, Identifying more epidemic clones during a hospital outbreak of multidrug-resistant Acinetobacter baumannii, PLoS ONE 2012;7(9):e45758.
• 2011
  Grimaldi-Bensouda L, Begaud B, Lert F, Rouillon F, Massol J, Guillemot D, Avouac B, Duru G, Magnier AM, Rossignol M, Abenhaim L, , Benchmarking the burden of 100 diseases: results of a nationwide representative survey within general practices, BMJ Open 2011;1(2):e000215.
• 2011
  Kardas-Sloma L, Boëlle PY, Opatowski L, Brun-Buisson C, Guillemot D, Temime L., Impact of antibiotic exposure patterns on selection of community-associated methicillin-resistant Staphylococcus aureus in hospital settings, Antimicrob Agents Chemother. 2011 Oct;55(10):4888-95..
• 2011
  Domenech de Cellès M, Opatowski L, Salomon J, Varon E, Carbon C, Boëlle PY, Guillemot D, Intrinsic epidemicity of Streptococcus pneumoniae depends on strain serotype and antibiotic susceptibility pattern, Antimicrob. Agents Chemother. 2011 Nov;55(11):5255-61.
• 2011
  Opatowski L, Guillemot D, Boëlle PY, Temime L., Contribution of mathematical modeling to the fight against bacterial antibiotic resistance, Curr Opin Infect Dis. 2011 Jun;24(3):279-87..
• 2011
  Opatowski L, Guillemot D, Boëlle PY, Temime L, Contribution of mathematical modeling to the fight against bacterial antibiotic resistance, Curr. Opin. Infect. Dis. 2011 Jun;24(3):279-87.
• 2010
  Lardon Z, Watier L, Brunet A, Bernède C, Goudal M, Dacheux L, Rotivel Y, Guillemot D, Bourhy H, Imported episodic rabies increases patient demand for and physician delivery of antirabies prophylaxis, PLoS Negl Trop Dis 2010 Jun;4(6):e723.
• 2010
  Opatowski L, Mandel J, Varon E, Boëlle PY, Temime L, Guillemot D., Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamics, Antimicrob Agents Chemother. 2010 Jun;54(6):2330-7.
• 2010
  Opatowski L, Mandel J, Varon E, Boëlle PY, Temime L, Guillemot D, Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamics, Antimicrob. Agents Chemother. 2010 Jun;54(6):2330-7.
• 2010
  Temime L, Kardas L, Opatowski L, Brun-Buisson C, Boëll eP-Y. and Guillemot D., NOSOSIM: an agent-based model of pathogen circulation in a hospital ward, International Conference on Computational Science, ICCS 2010. Procedia Computer Science 1. 2010.
• 2009
  Temime L, Opatowski L, Pannet Y, Brun-Buisson C, Boëlle PY, Guillemot D., Peripatetic health-care workers as potential superspreaders, Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18420-5.
• 2009
  Launay O, Toneatti C, Bernède C, Njamkepo E, Petitprez K, Leblond A, Larnaudie S, Goujon C, Ungeheuer MN, Ajana F, Raccurt C, Beytout J, Chidiac C, Bouhour D, Guillemot D, Guiso N, Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations, Hum Vaccin 2009 May;5(5):341-6.
• 2008
  Temime L, Boelle PY, Opatowski L, Guillemot D., Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population, PLoS One. 2008 Sep 19;3(9):e3244.
• 2008
  Opatowski L, Temime L, Varon E, Leclercq R, Leclerc R, Drugeon H, Boëlle PY, Guillemot D, Antibiotic innovation may contribute to slowing the dissemination of multiresistant Streptococcus pneumoniae: the example of ketolides, PLoS ONE 2008;3(5):e2089.
• 2008
  Opatowski L, Temime L, Varon E, Leclercq R, Drugeon H, Boëlle PY, Guillemot D., Antibiotic innovation may contribute to slowing the dissemination of multiresistant Streptococcus pneumoniae: the example of ketolides, PLoS One. 2008 May 7;3(5):e2089.
• 2005
  Guillemot D, Varon E, Bernède C, Weber P, Henriet L, Simon S, Laurent C, Lecoeur H, Carbon C, Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae, Clin. Infect. Dis. 2005 Oct;41(7):930-8.
• 2005
  Guillemot D, France G, Fender P, , Methodology for the evaluation and measurement of therapeutic progress, Therapie 2005 Jul-Aug;60(4):359-62, 363-6.
• 2004
  Guillemot D, Bonacorsi S, Blanchard JS, Weber P, Simon S, Guesnon B, Bingen E, Carbon C, Amoxicillin-clavulanate therapy increases childhood nasal colonization by methicillin-susceptible Staphylococcus aureus strains producing high levels of penicillinase, Antimicrob. Agents Chemother. 2004 Dec;48(12):4618-23.
• 2004
  Sommet A, Sermet C, Boëlle PY, Tafflet M, Bernède C, Guillemot D, No significant decrease in antibiotic use from 1992 to 2000, in the French community, J. Antimicrob. Chemother. 2004 Aug;54(2):524-8.
• 2002
  Guillemot D, Crémieux AC, Courvalin P, Evolution of antimicrobial resistance: impact on antibiotic use, Semin Respir Crit Care Med 2002 Oct;23(5):449-56.